Results 11 to 20 of about 752,857 (303)

Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro [PDF]

open access: yes, 2017
Multi-drug strategies have been attempted to prolong the efficacy of existing antibiotics, but with limited success. Here we show that the evolution of multi-drug-resistant Escherichia coli can be manipulated in vitro by administering pairs of ...
Cronin, Leroy   +5 more
core   +1 more source

Multi drug resistant tuberculosis

open access: yesThe Indian Journal of Pediatrics, 1996
The prevalence of multi-drug resistant tuberculosis is increasing globally which has upset tuberculosis treatment and control programmes. The problem has been further complicated by co-infection with HIV virus. Treatment of multi drug resistant tuberculosis is difficult, expensive and requires long duration chemotherapy. The long term prognosis is poor
A B, Dey, K, Nagarkar
openaire   +4 more sources

Effect of Anti-Tuberculosis Multi Drug Resistance Regimen on Hematological Lung Tuberculosis Patients Profile with Multi Drug Resistance

open access: yesBerkala Kedokteran, 2018
: ATD administration of tuberculosis in combination and duration often causes multi drug resistance (MDR) ATD due to discontinuation of treatment. Reported hematologic abnormal changes due to ATD.
Pradana Maulana Putra
doaj   +1 more source

Multi-label classification for multi-drug resistance prediction of Escherichia coli

open access: yesComputational and Structural Biotechnology Journal, 2022
Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria.
Yunxiao Ren   +7 more
doaj   +1 more source

Multi-drug resistant Gram-negative bacteria: antibiotic-resistance and new treatment strategies [PDF]

open access: yes, 2017
In this editorial, we treat the multi-drug-resistance of microorganisms such as Klebsiella pneumonia (Kp) and Acinetobacter baumanii and the issues concerning the management of these infections.
Angelis, Massimiliano De   +2 more
core   +1 more source

The evolution of resistance to synergistic multi‐drug combinations is more complex than evolving resistance to each individual drug component

open access: yesEvolutionary Applications, 2023
Multidrug antibiotic resistance is an urgent public health concern. Multiple strategies have been suggested to alleviate this problem, including the use of antibiotic combinations and cyclic therapies.
Natalie Ann Lozano‐Huntelman   +11 more
doaj   +1 more source

Disinfectant-susceptibility of multi-drug-resistant Mycobacterium tuberculosis isolated in Japan

open access: yesAntimicrobial Resistance and Infection Control, 2016
Background Multi-drug-resistant Mycobacterium tuberculosis has been an important problem in public health around the world. However, limited information about disinfectant-susceptibility of multi-drug-resistant strain of M.
Noriko Shinoda   +3 more
doaj   +1 more source

Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. [PDF]

open access: yes, 2017
The practice of phage therapy, which uses bacterial viruses (phages) to treat bacterial infections, has been around for almost a century. The universal decline in the effectiveness of antibiotics has generated renewed interest in revisiting this practice.
Koskella, Britt, Lin, Derek, Lin, Henry
core   +1 more source

Psychogenetic, genetic and epigenetic mechanisms in Candida auris: Role in drug resistance

open access: yesJournal of Infection and Public Health, 2023
In recent years, we are facing the challenge of drug resistance emergence in fungi. The availability of limited antifungals and development of multi-drug resistance in fungal pathogens has become a serious concern in the past years in the health sector ...
Ali A. Rabaan   +18 more
doaj   +1 more source

Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. [PDF]

open access: yes, 2006
Artemisinin-based combination therapies (ACTs) are recommended for use against uncomplicated malaria in areas of multi-drug resistant malaria, such as sub-Saharan Africa.
Kefas Mugittu   +15 more
core   +2 more sources

Home - About - Disclaimer - Privacy